Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 16 open reading frame 90 (C16orf90) encodes a small (~21 kDa), soluble, uncharacterized human protein with four alpha-helix domains and a nuclear localization signal at its C-terminus[2][4]. The gene is located at 16p13.3, spans 3169 nucleotides on the reverse strand, and has three exons. C16orf90 is primarily expressed in the testes and at low levels throughout other tissues. Evidence from microarray and post-translational modification studies suggests possible roles in the biological stress response and apoptosis, but its exact function remains unclear. Evolutionarily, it is present across mammals, with conservation particularly in exons 2 and 3. Clinically, variants in C16orf90 have been identified as potentially pathogenic in some cases of intellectual disability, but no direct evidence currently supports its use as a biomarker, therapeutic target, or in drug interaction studies[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 16 open reading frame 90 (C16orf90).